<h1>SMS Pharmaceuticals Ltd Schedules Board Meeting to Approve Q1 Financial Results</h1>
SMS Pharmaceuticals Limited has scheduled a meeting of its Board of Directors to consider and approve the Unaudited (Standalone and Consolidated) Financial Results for the first quarter ending June 30, 2026.
The Board meeting is set to take place on Saturday, August 1, 2026, at the company's registered office. The primary objective of the meeting is the review and approval of the financial results pertaining to the first quarter concluded on June 30, 2026.
In adherence to established protocols regarding the prevention of insider trading, SMS Pharmaceuticals Limited has announced details concerning the trading window for its equity shares. The company confirmed that the Trading Window closed starting July 1, 2026, and will remain restricted until August 3, 2026. The market for the stock is scheduled to reopen on August 4, 2026.
SMSPHARMA Stock Price Movement
On Friday, SMS Pharmaceuticals Limited shareholders saw the stock ascend to close at ₹385.95, gaining ₹1.30 or 0.34%. The company traded a volume of 48,295 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.